Focus shifting towards the US – Preparations underway
Some significant events during the quarter were:
– NeoDynamics completed a rights issue raising approx. SEK 69.3 million before transaction costs, increasing the number of shares by 60,250,592 to 120,501,184, and the share capital by SEK 6,025,059 to SEK 12,050,118.
– NeoDynamics was approved for trading on Nasdaq First North Growth Market in Stockholm, where the share began trading on May 2, 2022.
– The annual general meeting held on May 12, reelected the Board of Directors.
“The groundwork for the US commercialization and subsequent launch are in full swing. The team is working in parallel with the FDA approval process to ensure that there are no unnecessary delays, but the 510(k) application process is dependent on the FDA’s internal processes. The dialogue with the authority has been constructive and we expect that the process will be concluded before long. I remain convinced that NeoDynamics will be able to take the first steps in commercialising the NeoNavia system in the US before the year-end.” Says CEO Anna Eriksrud.
Disclaimer: HC Andersen Capital receives payment from NeoDynamics for a DigitalIR/Corporate Visibility agreement.